Nektar Therapeutics

NKTR • NASDAQ • Stock Fundamentals

Nektar Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Howard W. Robin, with a market cap of $2.0B.

Market Cap$2.0B

Employees137.0

CEOHoward W. Robin

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026

Next EarningsAug 6, 2026 · in 2 monthsAfter Market Close · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Nektar Therapeutics

Nektar Therapeutics (NKTR) has a market capitalization of $2.0B and trades on NASDAQ.

Nektar Therapeutics has approximately 137 employees.